DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / P•••••• B••••••••• P•••••••
P•••••• B••••••••• P•••••••
Institutional venture firmSan Francisco, CAp•••••••••.comSEC venture capital fund adviserone firm, 2 filing advisers
This firm files as 2 advisers on p•••••••••.com: P•••••• B••••••••• P••••••• C•• I••••••••• A•••••• L••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
P•••••• L••• S••••••• specializes in providing capital to innovative companies developing therapeutic products to address major unmet medical needs.
venture manager, reported GAV $581M across 3 vehicles
Importance
25
moderate
Active deployment
8
low
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
6
low
Identity and regulatory footprint
- Headquarters
- San Francisco, CAadviserinfo.sec.gov
- Office address
- 501 SECOND STREET, SUITE 200, San Francisco, CA, 94107adviserinfo.sec.gov
- Business phone
- 415 697 1002adviserinfo.sec.gov
- Website
- p•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Jun 25, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $586Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- P•••••• L••• S••••••• H••••••• L•••••• (Shareholder), E; N•• F••• S••••••• H••••••• L•••••• (Shareholder), E; N• I••••••••• H••••••• L•••••• (Shareholder), E; N•• F••• I••••••••• H••••••• L•••••• (Shareholder), E; N•• F••• G•••• H••••••• L•••••• (Shareholder), E; C••••• G•••• H••••••• L•••••• (Shareholder), E; C••••• G•••• I••••••••• L•••••• (Shareholder), E; P•••••• B••••••••• P••••••• F••• I• U••••• L••• (General Partner Of P•••••• B••••••••• P••••••• Fund I G.P., L.P.), E; P•••••• B••••••••• P••••••• M••••••••• L••• (Member), E; P•••••• P••••••• L••• (Owner Of P•••••• B••••••••• P••••••• Fund Ii G.P., Ltd.), E
- business phone
- 415 697 1002adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech
- Stages
- not stated or not yet read
- Geography
- boston, europe, global, north america, united states
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
unknown 100%
lead rate 0%follow-on rate 0%new logos, 12 months 2
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| P•••••• B••••••••• P••••••• F••• I•• L••• | Fund | 2022 adv first reported | Active deployment | $378M May 30, 2024 | 14 | $0 | Apr 23, 2021 |
| P•••••• B••••••••• P••••••• F••• I• L••• | Fund | 2017 form d first sale | Harvest | $203M May 30, 2024 | 7 | $298M | Mar 29, 2018 |
| S•••• 2•••• L••• | Fund | unknown | Fundraising | unknown | unknown | $0 | Oct 28, 2025 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
6 current, 2 departed
P•••••• P••••• E•••••
OtherPortfolio
U••••• S•••••
OtherInvestment
P•••• T•••• B•••••••
PartnerManaging Director · since Jun 1, 2022
B•••• K•• K••• T••
Platform and operationsOfficer · since Mar 1, 2018
M•••••• L••••••• T••••••
Platform and operationsCorporate Counsel And Chief Operating Officer · since Aug 1, 2022
R••••• L•••• H••••••
Platform and operationsOfficer · since Dec 1, 2017
2 departed (kept with end dates)
- H•••••• P•••••• · Officer · Jul 1, 2018 to Jun 28, 2022 Inference
- T•••• M• S••••• · Officer · Dec 1, 2016 to Jun 29, 2018 Inference
Investments on record
2 edges, 2 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| W•••••• b• 2• F••••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 12, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| C•••••••• T••••••••• | Series B · Series B | participant | unknown | $130M | unknown | Jul 22, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
12 relationships from shared deals, counted for the whole firm
Wellington Management 1 shared · one timeKCap Biotechnology Fund 1 shared · one timeHBM Healthcare Investments 1 shared · one timePerceptive Xontogeny Venture Funds 1 shared · one timeTrails Edge Capital Partners 1 shared · one timeCatalys Pacific 1 shared · one timeSR One 1 shared · one timeCormorant Asset Management 1 shared · one timeFrazier L••• S••••••• 1 shared · one time · they led 1Lightstone Ventures 1 shared · one timeSoleus Capital Management, L.P. 1 shared · one timeP•••••• 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Aug 1, 2022M•••••• L••••••• T•••••• joined Schedule A of P•••••• B••••••••• P••••••• as Corporate Counsel And Chief Operating Officer
- Jun 28, 2022P•••••• B••••••••• P••••••• F••• I•• L••• first reported on Form ADV by P•••••• B••••••••• P••••••• (Venture Capital Fund), GAV $383,961,335Fund first reported on Form ADVFundsFactP•••••• B••••••••• P••••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 28, 2022H•••••• P•••••• (Officer) no longer on Schedule A of P•••••• B••••••••• P•••••••
- Jun 1, 2022P•••• T•••• B••••••• joined Schedule A of P•••••• B••••••••• P••••••• as Managing Director
- Jul 1, 2018H•••••• P•••••• joined Schedule A of P•••••• B••••••••• P••••••• as Officer
- Jun 29, 2018T•••• M• S••••• (Officer) no longer on Schedule A of P•••••• B••••••••• P•••••••
- Mar 1, 2018B•••• K•• K••• T•• joined Schedule A of P•••••• B••••••••• P••••••• as Officer
- Dec 1, 2017R••••• L•••• H•••••• joined Schedule A of P•••••• B••••••••• P••••••• as Officer
- Mar 16, 2017P•••••• B••••••••• P••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 16, 2017P•••••• B••••••••• P••••••• F••• I• L••• first reported on Form ADV by P•••••• B••••••••• P••••••• (Venture Capital Fund), GAV $10,000,000Fund first reported on Form ADVFundsFactP•••••• B••••••••• P••••••• F••• I• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $581M across 3 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $581M across 2 vehicles
Evidence
55 observations from 3 sources